Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer
Overview
Authors
Affiliations
Currently, sensitive and specific methods for the detection and prognosis of early stage PCa are lacking. To establish the diagnosis and further identify an appropriate treatment strategy, prostate specific antigen (PSA) blood test followed by tissue biopsy have to be performed. The combination of tests is justified by the lack of a highly sensitive, specific, and safe single test. Tissue biopsy is specific but invasive and may have severe side effects, and therefore is inappropriate for screening of the disease. At the same time, the PSA blood test, which is conventionally used for PCa screening, has low specificity and may be elevated in the case of noncancerous prostate tumors and inflammatory conditions, including benign prostatic hyperplasia and prostatitis. Thus, diverse techniques of liquid biopsy have been investigated to supplement or replace the existing tests of prostate cancer early diagnosis and prognostics. Here, we provide a review on the advances in diagnosis and prognostics of non-metastatic prostate cancer by means of various biomarkers extracted via liquid biopsy, including circulating tumor cells, exosomal miRNAs, and circulating DNAs.
Hamid Y, Rabbani R, Afsara R, Nowrin S, Ghose A, Papadopoulos V Int J Mol Sci. 2025; 26(2).
PMID: 39859516 PMC: 11765602. DOI: 10.3390/ijms26020802.
Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis.
Li Y, Ma L, Chen H, Jin Z, Yang W, Qiao Y Discov Oncol. 2024; 15(1):307.
PMID: 39048891 PMC: 11269540. DOI: 10.1007/s12672-024-01183-x.
Liquid biopsy to personalize treatment for metastatic prostate cancer.
Lopez-Valcarcel M, Lopez-Campos F, Zafra J, Cienfuegos I, Ferri M, Barrado M Am J Transl Res. 2024; 16(5):1531-1549.
PMID: 38883349 PMC: 11170619. DOI: 10.62347/DICU9510.
Clinical Significance of Extracellular Vesicles in Prostate and Renal Cancer.
Chen T, Mihalopoulos M, Zuluaga L, Rich J, Ganta T, Mehrazin R Int J Mol Sci. 2023; 24(19).
PMID: 37834162 PMC: 10573190. DOI: 10.3390/ijms241914713.
Huang H, Chen C, Chang K, Lee M, Lee C, Chao Y J Transl Med. 2023; 21(1):714.
PMID: 37821919 PMC: 10566053. DOI: 10.1186/s12967-023-04424-9.